Yamamura Sakura, Kawaguchi Takumi, Nakano Dan, Tomiyasu Yoshiko, Yoshinaga Shinobu, Doi Yumi, Takahashi Hirokazu, Anzai Keizo, Eguchi Yuichiro, Torimura Takuji, Shiba Naoto
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Medical Examination Section, Medical Examination Part Facilities, Public Utility Foundation Saga Prefectural Health Promotion Foundation, Saga, Japan.
Hepatol Res. 2020 Feb;50(2):199-213. doi: 10.1111/hepr.13436. Epub 2019 Nov 20.
Advanced hepatic fibrosis is seen in individuals with potential hepatocellular carcinoma and cardiovascular disease. Hepatic fibrosis can be assessed using a combination of the FIB-4 index and imaging modalities, including shear wave elastography. We aimed to investigate the prevalence of advanced fibrosis in the general population and the profiles associated with advanced fibrosis using a data-mining analysis.
We enrolled 1155 health checkup examinees (median age 53 years, 685 women, 470 male). Advanced fibrosis was defined by FIB-4 index ≥1.3 and liver stiffness ≥8.07 kPa using shear wave elastography. Participants were classified as normal-mild fibrosis (n = 1035) or advanced fibrosis (n = 120). Factors associated with advanced fibrosis were analyzed by logistic regression and decision-tree analyses.
Advanced fibrosis was observed in 10.4% of participants (120/1155). In the logistic regression analysis, independent factors for advanced fibrosis were age (≥75 years; OR 2.12, 95% CI 1.021-4.415; P = 0.0419) and the presence of metabolic syndrome (OR 2.51, 95% CI 1.416-4.462; P = 0.0017). The decision-tree analysis showed two profiles associated with advanced fibrosis: profile 1 - individuals aged ≥65 years with metabolic syndrome and mild-to-moderate alcohol consumption (prevalence of advanced fibrosis 73.3%); and profile 2 - individuals without metabolic syndrome, aged ≥75 years, with no exercise habit (prevalence of advanced fibrosis 56.3%).
Advanced fibrosis was observed in 10.4% of health checkup examinees. Furthermore, we showed that aging, metabolic syndrome with mild-to-moderate alcohol consumption, and physical inactivity were associated with advanced fibrosis. Thus, prevention of metabolic syndrome and alcohol withdrawal, as well as exercise habits, might inhibit the progression of hepatic fibrosis.
在潜在的肝细胞癌和心血管疾病患者中可观察到晚期肝纤维化。肝纤维化可通过FIB-4指数和包括剪切波弹性成像在内的成像方式联合评估。我们旨在通过数据挖掘分析调查普通人群中晚期纤维化的患病率以及与晚期纤维化相关的特征。
我们纳入了1155名健康体检者(中位年龄53岁,女性685名,男性470名)。晚期纤维化的定义为FIB-4指数≥1.3且使用剪切波弹性成像测得肝脏硬度≥8.07kPa。参与者被分为正常-轻度纤维化组(n = 1035)或晚期纤维化组(n = 120)。通过逻辑回归和决策树分析来分析与晚期纤维化相关的因素。
10.4%的参与者(120/1155)存在晚期纤维化。在逻辑回归分析中,晚期纤维化的独立因素为年龄(≥75岁;比值比2.12,95%置信区间1.021 - 4.415;P = 0.0419)和代谢综合征的存在(比值比2.51,95%置信区间1.416 - 4.462;P = 0.0017)。决策树分析显示了两种与晚期纤维化相关的特征:特征1 - 年龄≥65岁、患有代谢综合征且有轻度至中度饮酒习惯的个体(晚期纤维化患病率73.3%);特征2 - 无代谢综合征、年龄≥75岁且无运动习惯的个体(晚期纤维化患病率56.3%)。
10.4%的健康体检者存在晚期纤维化。此外,我们发现衰老、伴有轻度至中度饮酒习惯的代谢综合征以及缺乏运动与晚期纤维化有关。因此,预防代谢综合征、戒酒以及养成运动习惯可能会抑制肝纤维化的进展。